Literature DB >> 9491914

Nonsynonymous mutations within the human immunodeficiency virus type 1 p17 gene are clustered to sequences binding to the host human leukocyte antigen class I molecules.

M Birk1, A Vahlne, A Sönnerborg, M Sällberg.   

Abstract

We have analyzed the relation between intrapatient variabilities of the p17 gene and the location of known host p17 cytotoxic T lymphocyte (CTL) epitopes in five patients infected with human immunodeficiency virus type 1 (HIV-1). All patients were typed with respect to the human leukocyte antigen (HLA) class I type. One to seven previously fine-mapped p17 CTL epitopes corresponded to the HLA class I restriction elements of each patient. An average of 28+/-16% of the p17 gene of each patient encoded CTL epitopes corresponding to the HLA restriction elements of the host. Twenty full-length p17 gene clones were sequenced from each patient. The intrapatient homology between the p17 sequences ranged from 96.4 to 98.9%. The interpatient homology between the consensus sequences of each patient ranged from 83.1 to 91.6%. A total of 246 nucleotide differences within the 100 p17 clones was noted. Fifteen (16%) of 96 synonymous substitutions were found within host CTL epitopes, whereas 72 (48%) of 150 nonsynonymous nucleotide changes were found within CTL epitopes corresponding to the HLA restriction elements of the host (p < 0.0001; Fisher's exact test). Subsequently, variable residues indicating the evolution of at least two major p17 species (i.e., >20% of the clones) were determined to be more common at positions contained within these CTL epitopes (p < 0.01). The present data suggest that the evolution of the p17 gene is influenced by contact areas with the host HLA class I molecules.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9491914     DOI: 10.1089/aid.1998.14.241

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  4 in total

1.  Reappearance of founder virus sequence in human immunodeficiency virus type 1-infected patients.

Authors:  A C Karlsson; H Gaines; M Sällberg; S Lindbäck; A Sönnerborg
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Variability and immunogenicity of human immunodeficiency virus type 1 p24 gene quasispecies.

Authors:  J Iroegbu; M Birk; U Lazdina; A Sönnerborg; M Sällberg
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

3.  CD4+ T cell targeting of human immunodeficiency virus type 1 (HIV-1) peptide sequences present in vivo during chronic, progressive HIV-1 disease.

Authors:  Eli Boritz; Eric L Rapaport; Thomas B Campbell; John R Koeppe; Cara C Wilson
Journal:  Virology       Date:  2006-12-13       Impact factor: 3.616

4.  Identification of the core regulators of the HLA I-peptide binding process.

Authors:  Yu-Hang Zhang; Zhihao Xing; Chenglin Liu; ShaoPeng Wang; Tao Huang; Yu-Dong Cai; Xiangyin Kong
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.